Univariate and multivariate analysis of overall survival and disease-free survival of UTUC patients showed a worse prognosis of patients with higher expression levels of METTL4 and 6mA (Additional file 2: Tables S2 and S3). The gene discussed is METTL4; the disease is renal pelvis/ureter urothelial carcinoma.